Learning Objectives:

  1. Understand mechanistic underpinnings in the development of cardiorenal syndrome.

 

  1. Review recent data from diuretic trials and juxtaposing them with data on rapid GDMT deployment.  

 

  1. Understanding the concept of "renalism" as a barrier to optimizing decongestion and GDMT in patients with cardiorenal syndrome.
Session date: 
05/31/2024 - 12:00pm to 1:00pm CDT
Location: 
In-person / Zoom
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Janani Rangaswami, MD